MET MetLife Inc.

Scott+Scott, Attorneys at Law, LLP Alerts Investors to the Filing of a Securities Class Action Against MetLife, Inc. (MET)

Scott+Scott, Attorneys at Law, LLP (“Scott+Scott”), a national securities and consumer rights litigation firm, is notifying investors that a class action lawsuit has been filed against MetLife, Inc. (NYSE:MET) (“MetLife” or the “Company”) and certain of its officers, related to alleged violations of federal securities laws. If you purchased shares of MetLife common stock between February 27, 2013 and January 29, 2018, you are encouraged to a contact a Scott+Scott attorney at (844) 818-6982 for additional information.

MetLife provides life insurance, annuities, employee benefits, and asset management products in the United States and internationally.

The lawsuit alleges that Defendants made materially false and misleading statements regarding the Company’s business, operational and compliance policies; specifically, that: (1) MetLife’s practices and procedures used to estimate its reserves set aside for annuity and pension payments were inadequate; (2) MetLife had inadequate internal controls over financial reporting; and (3) as a result, statements about MetLife’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis.

On December 15, 2017, after-market, MetLife announced that the Company had been unable to locate some of the Company’s annuity beneficiaries and the Wall Street Journal published an article regarding the disclosure. On this news, shares of MetLife fell $0.62 per share, or over 1.2%, over the following two trading days to close at $50.79 per share on December 19, 2017.

On January 29, 2018, after-market, MetLife announced it would reschedule its earnings releases for fourth quarter and full year 2017, due to “material weaknesses” in its internal controls. The Company also advised it would have to revise certain of its prior financial statements, and that the Securities and Exchange Commission and the New York Department of Financial Services had made related inquiries.

On this news, shares of MetLife fell $6.28 per share or over 11.6% over the next two trading days to close at $47.67 per share on January 31, 2018.

What You Can Do

If you purchased MetLife stock between February 27, 2013, and January 29, 2018, inclusive, or if you have questions about this notice or your legal rights, please contact attorney Joe Pettigrew at (844) 818-6982, or at [email protected]. Investors have until April 6, 2018, to move for lead plaintiff.

About Scott+Scott, Attorneys at Law, LLP

Scott+Scott has significant experience in prosecuting major securities, antitrust, and employee retirement plan actions throughout the United States. The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Connecticut, California, and Ohio.

EN
07/02/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on MetLife Inc.

Moody's Ratings rates MetLife’s subordinated debentures Baa1 (hyb)

Please see for any updates on changes to the lead rating analyst and to the Moody's legal entity that has issued the rating. Please see the issuer/deal page on for additional regulatory disclosures for each credit rating. The rating of the deben...

Moody's Ratings rates MetLife’s subordinated debentures Baa1 (hyb)

New York , February 24, 2026 – Moody's Ratings (Moody's) has assigned a Baa1 (hyb) rating to the subordinated debentures issued by MetLife, Inc. (MetLife, NYSE: MET, senior debt A3). The debentures are being issued off MetLife's multi-purpose shelf registration statement filed in May 2025 and the pr...

Moody’s Ratings assigns ratings to MetLife’s shelf (senior unsecured a...

Moody’ s Ratings assigns ratings to MetLife’ s shelf. New York, January 5, 2026– Moody’ s Ratings has assigned provisional ratings to. MetLife, Inc.’ s shelf registration filed on May 16, 2025.

Metlife Inc: 1 director

A director at Metlife Inc sold/gave away 30,684 shares at 0.000USD and the significance rating of the trade was 74/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch